1088 What is the pre-treatment factor contributing to failure in improvement of over-active bladder symptoms following alpha-1 blocker administration in patients with benign prostatic hyperplasia accompanied by overactive bladder?
2018 ◽
Vol 200
(3)
◽
pp. 620-625
◽
2017 ◽
Vol 24
(7)
◽
pp. 525-531
◽
2006 ◽
Vol 13
(1)
◽
pp. 15-20
◽